Publication | Closed Access
Deflazacort for long-term maintenance of remission in type I autoimmune hepatitis.
34
Citations
0
References
1999
Year
deflazacort seems to be useful in maintaining remission of autoimmune hepatitis during a prolonged period of follow-up. Future studies should include a histological evaluation of the patients and a prospective comparative analysis of side-effects.